HTHT
Hemenway Trust Hemenway Trust Portfolio holdings
AUM
$1.29B
This Quarter Return
-0.45%
1 Year Return
+12.43%
3 Year Return
+67.12%
5 Year Return
+103.95%
10 Year Return
+272.81%
AUM
$1.23B
AUM Growth
+$1.23B
(-2.5%)
Cap. Flow
-$1.92M
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
42.55%
Holding
136
New
1
Increased
48
Reduced
60
Closed
11
Top Buys
| 1 |
Salesforce
CRM
|
$6.42M |
| 2 |
McCormick & Company Non-Voting
MKC
|
$5.68M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$3.74M |
| 4 |
Carrier Global
CARR
|
$2.78M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$1.45M |
Top Sells
| 1 |
Medtronic
MDT
|
$8.16M |
| 2 |
NVIDIA
NVDA
|
$4.94M |
| 3 |
Fiserv
FI
|
$2.96M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
$2.72M |
| 5 |
Aptiv
APTV
|
$2.26M |
Sector Composition
| 1 | Technology | 30.41% |
| 2 | Healthcare | 17.81% |
| 3 | Industrials | 12.79% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Financials | 5.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
PepsiCo
PEP
$206B
| $1.35M | 0.11% |
8,859
-2,980
| -25% | -$453K |
|
|
52
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.33M | 0.11% |
2,938
+76
| +3% | +$34.4K |
|
53
iShares Core S&P 500 ETF
IVV
$657B
| $1.13M | 0.09% |
1,924
+636
| +49% | +$374K |
|
54
Merck
MRK
$214B
| $987K | 0.08% |
9,924
+568
| +6% | +$56.5K |
|
55
iShares Russell 1000 ETF
IWB
$42.9B
| $931K | 0.08% |
2,890
-120
| -4% | -$38.7K |
|
56
Novo Nordisk
NVO
$251B
| $925K | 0.08% |
10,756
-200
| -2% | -$17.2K |
|
57
Stryker
SYK
$149B
| $884K | 0.07% |
2,455
-78
| -3% | -$28.1K |
|
58
EOG Resources
EOG
$68.8B
| $881K | 0.07% |
7,188
-125
| -2% | -$15.3K |
|
59
ASML
ASML
$285B
| $787K | 0.06% |
1,136
-25
| -2% | -$17.3K |
|
60
American Tower
AMT
$93.9B
| $767K | 0.06% |
4,184
-177
| -4% | -$32.5K |
|
61
Canadian Pacific Kansas City
CP
$70.2B
| $759K | 0.06% |
10,485
-820
| -7% | -$59.3K |
|
62
SPDR Portfolio S&P 500 ETF
SPLG
$82.9B
| $747K | 0.06% |
10,832
-150
| -1% | -$10.3K |
|
63
Visa
V
$679B
| $740K | 0.06% |
2,340
+337
| +17% | +$107K |
|
64
IBM
IBM
$225B
| $729K | 0.06% |
3,316
-21
| -0.6% | -$4.62K |
|
65
Novartis
NVS
$245B
| $667K | 0.05% |
6,854
-4,335
| -39% | -$422K |
|
66
Idexx Laboratories
IDXX
$51.2B
| $631K | 0.05% |
1,526
-126
| -8% | -$52.1K |
|
67
Mettler-Toledo International
MTD
$26.3B
| $612K | 0.05% |
500
-70
| -12% | -$85.7K |
|
68
Repligen
RGEN
$6.79B
| $612K | 0.05% |
4,250
| – | – |
|
69
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $589K | 0.05% |
12,323
+6,638
| +117% | +$317K |
|
70
Philip Morris
PM
$261B
| $549K | 0.04% |
4,564
-40
| -0.9% | -$4.81K |
|
71
Broadcom
AVGO
$1.4T
| $538K | 0.04% |
2,320
+630
| +37% | +$146K |
|
72
Chubb
CB
$110B
| $514K | 0.04% |
1,860
-40
| -2% | -$11.1K |
|
73
General Mills
GIS
$26.4B
| $507K | 0.04% |
7,957
-125
| -2% | -$7.97K |
|
74
Tesla
TSLA
$1.06T
| $495K | 0.04% |
1,225
-150
| -11% | -$60.6K |
|
75
Coca-Cola
KO
$297B
| $489K | 0.04% |
7,854
-540
| -6% | -$33.6K |
|